The Manufacturers Life Insurance Company boosted its position in agilon health, inc. (NYSE:AGL – Get Rating) by 27.7% in the third quarter, according to its most recent filing with the SEC. The institutional investor owned 52,327 shares of the company's stock after purchasing an additional 11,359 shares during the period. The Manufacturers Life Insurance Company's holdings in agilon health were worth $1,230,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in AGL. Barclays PLC grew its holdings in shares of agilon health by 80.0% in the third quarter. Barclays PLC now owns 89,962 shares of the company's stock valued at $2,106,000 after acquiring an additional 39,988 shares in the last quarter. Los Angeles Capital Management LLC grew its stake in agilon health by 52.2% in the 3rd quarter. Los Angeles Capital Management LLC now owns 165,443 shares of the company's stock valued at $3,875,000 after purchasing an additional 56,728 shares during the period. Victory Capital Management Inc. increased its position in shares of agilon health by 4.1% during the 3rd quarter. Victory Capital Management Inc. now owns 23,797 shares of the company's stock valued at $557,000 after purchasing an additional 942 shares during the last quarter. Kestra Advisory Services LLC purchased a new stake in shares of agilon health during the 3rd quarter valued at $1,068,000. Finally, Maryland State Retirement & Pension System boosted its holdings in shares of agilon health by 14.5% in the 3rd quarter. Maryland State Retirement & Pension System now owns 14,658 shares of the company's stock worth $343,000 after buying an additional 1,855 shares during the last quarter.
Get agilon health alerts:Insider Transactions at agilon health
In related news, insider Benjamin Kornitzer sold 5,398 shares of the business's stock in a transaction that occurred on Friday, December 16th. The shares were sold at an average price of $16.82, for a total transaction of $90,794.36. Following the completion of the transaction, the insider now owns 10,426 shares of the company's stock, valued at $175,365.32. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other news, insider Benjamin Shaker sold 20,723 shares of agilon health stock in a transaction dated Wednesday, January 18th. The stock was sold at an average price of $19.78, for a total transaction of $409,900.94. Following the completion of the sale, the insider now owns 25,625 shares in the company, valued at approximately $506,862.50. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Benjamin Kornitzer sold 5,398 shares of the company's stock in a transaction that occurred on Friday, December 16th. The stock was sold at an average price of $16.82, for a total transaction of $90,794.36. Following the completion of the transaction, the insider now owns 10,426 shares in the company, valued at $175,365.32. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 39,613 shares of company stock valued at $746,114. 3.30% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
AGL has been the topic of a number of research analyst reports. Wells Fargo & Company dropped their target price on shares of agilon health from $28.00 to $22.00 and set an "overweight" rating on the stock in a research note on Tuesday, November 15th. The Goldman Sachs Group dropped their price objective on agilon health from $38.00 to $34.00 and set a "buy" rating on the stock in a research note on Tuesday, November 15th. SVB Leerink lowered their target price on agilon health from $33.00 to $30.00 and set an "outperform" rating on the stock in a research note on Friday, November 4th. Finally, Stifel Nicolaus initiated coverage on agilon health in a research report on Thursday, December 8th. They set a "buy" rating and a $23.00 price target on the stock. One analyst has rated the stock with a hold rating and seven have given a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $28.38.agilon health Price Performance
Shares of NYSE AGL opened at $22.05 on Monday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.48 and a current ratio of 2.48. agilon health, inc. has a fifty-two week low of $14.82 and a fifty-two week high of $28.36. The stock has a market cap of $9.08 billion, a PE ratio of -84.81 and a beta of 1.09. The stock has a fifty day moving average of $18.19 and a 200-day moving average of $20.57.
agilon health (NYSE:AGL – Get Rating) last issued its earnings results on Thursday, November 3rd. The company reported ($0.07) EPS for the quarter, missing the consensus estimate of ($0.05) by ($0.02). agilon health had a negative return on equity of 9.31% and a negative net margin of 4.30%. The company had revenue of $694.86 million during the quarter, compared to the consensus estimate of $651.24 million. Equities research analysts anticipate that agilon health, inc. will post -0.21 earnings per share for the current year.
agilon health Profile
(Get Rating)
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. As of December 31, 2021, it served approximately 238,000 senior members, which included 186,300 medicare advantage members and 51,700 medicare fee-for-service beneficiaries.
Featured Articles
- Get a free copy of the StockNews.com research report on agilon health (AGL)
- Is C3.ai Artificial Intelligence Product Suite a Gamechanger?
- MarketBeat Week in Review – 1/30 – 2/3
- Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
- Zimmer Biomet Beats on Earnings, Growth May be Priced In
- AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.